Showing results (91-100 of 118) with videos related to
Sort By:
Pageof 12
Pathogens (Basel, Switzerland)|July 27, 2022
Correction: Dusabimana et al. Surveillance for Onchocerciasis-Associated Epilepsy and Ov16 IgG4 Testing of Children 6-10 Years Old Should Be Used to Identify Areas Where Onchocerciasis Elimination Programs Need Strengthening. <i>Pathogens</i> 2022, <i>11</i>, 281Alfred Dusabimana, Joseph Nelson Siewe Fodjo, Michel Mandro Ndahura, et al.Pathogens (Basel, Switzerland)|March 26, 2022
Surveillance for Onchocerciasis-Associated Epilepsy and OV16 IgG4 Testing of Children 6-10 Years Old Should Be Used to Identify Areas Where Onchocerciasis Elimination Programs Need StrengtheningAlfred Dusabimana, Joseph Nelson Siewe Fodjo, Michel Mandro Ndahura, et al.Plos Neglected Tropical Diseases|September 8, 2025
Community-directed treatment with ivermectin in Maridi, South Sudan: Impact of an onchocerciasis awareness campaign and bi-annual treatment on therapeutic coverageJoseph Nelson Siewe Fodjo, Moses Okwii, Stephen Raimon Jada, et al.BMJ Open|September 3, 2021
'Slash and clear' vector control for onchocerciasis elimination and epilepsy prevention: a protocol of a cluster randomised trial in Cameroonian villagesJoseph Nelson Siewe Fodjo, Melissa Krizia Vieri, Leonard Ngarka, et al.Frontiers in Public Health|November 25, 2022
Adherence to COVID-19 preventive measures in Sub-Saharan Africa during the 1st year of the pandemic: Pooled analysis of the International Citizen Project on COVID-19 (ICPCovid) surveysLeonard Ngarka, Joseph Nelson Siewe Fodjo, Wepnyu Yembe Njamnshi, et al.Plos Neglected Tropical Diseases|January 11, 2020
Ivermectin as an adjuvant to anti-epileptic treatment in persons with onchocerciasis-associated epilepsy: A randomized proof-of-concept clinical trialMichel Mandro, Joseph Nelson Siewe Fodjo, Deby Mukendi, et al.Research and Reports in Tropical Medicine|December 30, 2024
The Spectrum of Ocular Diseases in the Onchocerciasis-Endemic Focus of Raga in South SudanKenneth Lado Sube, Joseph Daniel Wani Lako, Justin Bruno Tongun, et al.Plos Neglected Tropical Diseases|February 5, 2026
Reaching the last mile with ivermectin mass drug administration against onchocerciasis: The case of Kwanware-Ottou persistent transmission focus in the Wenchi health district of GhanaRogers Nditanchou, Akinola Stephen Oluwole, Sapana Basnet, et al.Parasites & Vectors|March 21, 2019
Impact of 19 years of mass drug administration with ivermectin on epilepsy burden in a hyperendemic onchocerciasis area in CameroonCharlotte Boullé, Alfred K Njamnshi, Fidèle Dema, et al.Plos Neglected Tropical Diseases|February 27, 2026
Point participation does not reflect long‑term treatment adherence: An evaluation of ivermectin MDA in the Kwanware‑Ottou persistent onchocerciasis transmission focus, Wenchi, GhanaRogers Nditanchou, Akinola Stephen Oluwole, Judith Saare, et al.Pageof 12